Margin trendWarning
영업외손익 급변 (영업이익 대비 268% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.
₩6,500+0.93%
2026-10-08 closeHwail Pharmaceutical's published financial data is dated 2026-10-04. 2024 revenue was KRW 119.76B. 2024 operating profit was −KRW 924M.
Reported results
Financial safety
Reference indicatorAs of 2024Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 22.47
Distress
Grey
Safe
- Altman Z''
- 22.47
- Beneish M-Score
- -2.29
- Sloan accrual
- -2.39%
No statistical flag
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
6/9Moderate
Piotroski measures year-over-year financial improvement, not absolute quality.
Financial improvement score6/9
Profitability
- Positive ROAPass
- Positive OCFPass
- Improving ΔROAPass
- Accruals (OCF > net income)Pass
Leverage & liquidity
- Lower debtPass
- Higher current ratioNot passed
- No new sharesPass
Efficiency
- Higher gross marginNot passed
- Higher asset turnoverNot passed
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Forensic signals
Anomaly and structural signals observed in the financial statements.
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- -0.8%
- Interest coverage
- -2.6x
- Return on equity (ROE)
- 3.2%
Operating margin −5pp
Operating lossInterest coverageBase -2.6x adverse case -19.4x
Return on equity (ROE)Base 3.2% adverse case -3.6%
Revenue −15%
Interest coverage riskInterest coverageBase -2.6x adverse case -2.2x
Return on equity (ROE)Base 3.2% adverse case -0.6%
Interest rate +2pp
Interest coverage riskInterest coverageBase -2.6x adverse case -1.5x
Return on equity (ROE)Base 3.2% adverse case -0.7%
Interest coverage limit
Already below the limit by 1.1ppInterest coverage limit at an operating margin of 0.3%
Interest expense coverage threshold
Quantus Signal · live data · not investment advice · Privacy Policy